Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126780122 | 12678012 | 2 | F | 20160116 | 20160824 | 20160823 | 20160831 | EXP | FR-PFIZER INC-2016389872 | PFIZER | 63.00 | YR | M | Y | 76.00000 | KG | 20160831 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126780122 | 12678012 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous drip | 2 MG, DAILY (CYCLIC) | 71484 | 2 | MG | ||||||||
126780122 | 12678012 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | UNK | 11719 | ||||||||||
126780122 | 12678012 | 3 | SS | DOXORUBICIN TEVA | DOXORUBICIN | 1 | Intravenous drip | 97 MG, DAILY (CYCLIC) | 0 | 97 | MG | SOLUTION FOR INJECTION/INFUSION | |||||||
126780122 | 12678012 | 4 | SS | ENDOXAN /00021101/ | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 1450 MG, DAILY (CYCLIC) | 0 | 1450 | MG | ||||||||
126780122 | 12678012 | 5 | SS | ETOPOSIDE TEVA | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 190 MG, DAILY (CYCLIC) | 0 | 190 | MG | SOLUTION FOR INFUSION | |||||||
126780122 | 12678012 | 6 | SS | METHYLPREDNISOLONE MYLAN /00049602/ | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous drip | 100 MG, DAILY (CYCLIC) | 0 | 100 | MG | ||||||||
126780122 | 12678012 | 7 | SS | CORTANCYL | PREDNISONE | 1 | Oral | 115 MG, DAILY | 0 | 115 | MG | ||||||||
126780122 | 12678012 | 8 | C | ONDANSETRON ACCORD | ONDANSETRON | 1 | Intravenous drip | 8 MG, DAILY | 0 | 8 | MG | ||||||||
126780122 | 12678012 | 9 | C | GRANOCYTE | LENOGRASTIM | 1 | UNK | 0 | |||||||||||
126780122 | 12678012 | 10 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | BID | |||||||
126780122 | 12678012 | 11 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | |||||||||||
126780122 | 12678012 | 12 | C | LEDERFOLINE | LEUCOVORIN CALCIUM | 1 | Oral | 25 MG, WEEKLY | 0 | 25 | MG | /wk | |||||||
126780122 | 12678012 | 13 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126780122 | 12678012 | 10 | Prophylaxis |
126780122 | 12678012 | 11 | Prophylaxis |
126780122 | 12678012 | 12 | Prophylaxis |
126780122 | 12678012 | 13 | Hyperuricaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126780122 | 12678012 | DE |
126780122 | 12678012 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126780122 | 12678012 | Acute prerenal failure | |
126780122 | 12678012 | Febrile bone marrow aplasia | |
126780122 | 12678012 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126780122 | 12678012 | 1 | 20160106 | 20160106 | 0 | |
126780122 | 12678012 | 2 | 20160106 | 20160106 | 0 | |
126780122 | 12678012 | 3 | 20160106 | 20160106 | 0 | |
126780122 | 12678012 | 4 | 20160106 | 20160106 | 0 | |
126780122 | 12678012 | 5 | 20160107 | 20160108 | 0 | |
126780122 | 12678012 | 6 | 20160106 | 20160108 | 0 | |
126780122 | 12678012 | 7 | 20160109 | 20160110 | 0 | |
126780122 | 12678012 | 8 | 20160106 | 20160108 | 0 | |
126780122 | 12678012 | 9 | 20160111 | 20160117 | 0 |